Each CD includes the full-color, searchable, PDF files of articles and formulations from the Journal.

CD Prices
1 = $95
2 to 5 = $85 each
6 to 9 = $75 each
10 + = $65 each

Library CD
Volume 18, 2014 CD
Six back issues from 2014 on one convenient CD.
Permanent storage and easy retrieval of IJPC articles and formulations.
Only $95 per CD
  • Print journal articles in color from the PDF file for your marketing needs.
  • Eliminate long searches through past issues for formulations, compatibility studies, standard operating procedures, marketing ideas, and literature reviews.

This CD contains the following articles listed by volume, issue and page number:

Issues Included
Volume/Issue Date Title
Vol. 18 No. 1 January/February 2014 Volume 18, Number 1
Vol. 18 No. 2 March/April 2014 Volume 18, Number 2
Vol. 18 No. 3 May/June 2014 Volume 18, Number 3
Vol. 18 No. 4 July/August 2014 Volume 18, Number 4
Vol. 18 No. 5 September/October 2014 Volume 18, Number 5
Vol. 18 No. 6 November/December 2014 Volume 18, Number 6

Volume 18, 2014 CD ARTICLES

Volume18, 2014 CD ARTICLES
Title (Click for Details) Vol/Issue Page
PreScription: The International Journal of Pharmaceutical Compounding Begins Its 18th Year Vol. 18 No. 1 4
The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013 Vol. 18 No. 1 6
Using Compounded Medications for the Topical Treatment of Complex Regional Pain Syndrome Type I Following Trauma: A Case Report Vol. 18 No. 1 14
Good Enough for America Vol. 18 No. 1 20
Determination of Risk for Sterile Preparations Vol. 18 No. 1 30
U.S. Food and Drug Administration Requests for Input on HR 3204 Enactment: The Drug Quality and Security Act of 2013 Vol. 18 No. 1 35
Marketing Vol. 18 No. 1 38
Tips and Hints: Powders, Capsules, Tablets, Suppositories, and Sticks Vol. 18 No. 1 42
Quality Control Analytical Methods: Laboratory Considerations of United States Pharmacopeia Chapter <71> Sterile Tests and Its Application to Pharmaceutical Compounding Vol. 18 No. 1 46
Basics of Sterile Compounding: Bubble Point Testing Vol. 18 No. 1 54
Calculations Vol. 18 No. 1 58
Aztreonam Injection Vol. 18 No. 1 60
Bumetanide 0.25-mg/mL Injection Vol. 18 No. 1 61
Droperidol 2.5-mg/mL Injection Vol. 18 No. 1 62
Lomustine 100-mg Capsules Vol. 18 No. 1 63
Neostigmine Bromide 15-mg Capsules Vol. 18 No. 1 64
Nimodipine 30-mg Capsules Vol. 18 No. 1 65
Phenobarbital 60-mg Capsules Vol. 18 No. 1 66
Potassium Chloride 2-mEq/mL Injection Vol. 18 No. 1 67
Procainamide Hydrochloride 100-mg/mL Injection Vol. 18 No. 1 68
Vasopressin 20-units/mL Injection Vol. 18 No. 1 69
The Effectiveness of Sublingual and Topical Compounded Bioidentical Hormone Replacement Therapy in Post-menopausal Women: An Observational Cohort Study Vol. 18 No. 1 70
Long-term Stability of Morphine Hydrochloride in 0.9% NaCl Infusion Polyolefin Bags After Freeze-thaw Treatment and in Polypropylene Syringes at 5°C ± 3°C Vol. 18 No. 1 78
E-Prescribing Errors Identified in a Compounding Pharmacy: A Quality-improvement Project Vol. 18 No. 1 83
PostScription: Pharmacy Benefit Managers and Compounding Pharmacists: Billing for Services Vol. 18 No. 1 87
PreScription: Standards vs Opinions Vol. 18 No. 2 92
A Needle-free Reconstitution and Transfer System for Compounded Sterile Intravenous Drug Solutions: In Compliance with United States Pharmacopeia Chapter <797> Standards Vol. 18 No. 2 94
Pharmaceutical Compounding or Pharmaceutical Manufacturing? A Regulatory Perspective Vol. 18 No. 2 101
Compounding Practices in Iran Vol. 18 No. 2 112
IACP's Continuing Support of Compounding Pharmacists: Letter to the FDA Concerning 503B Outsourcing Facilities Vol. 18 No. 2 117
Effective Advertisements Vol. 18 No. 2 120
Quality Control Analytical Methods: The Essentials of United States Pharmacopeia Chapter <51> Antimicrobial Effectiveness Testing and Its Application in Pharmaceutical Compounding Vol. 18 No. 2 123
Basics of Sterile Compounding: Compounding by Weight Versus Compounding by Volume Vol. 18 No. 2 131
Basics of Compounding: Tips and Hints, Part 2: Compounding with Solutions, Suspensions, Emulsions, and Lotions Vol. 18 No. 2 137
Calculations Vol. 18 No. 2 140
Doxazosin 1-mg, 2-mg, 4-mg, or 8-mg Capsules Vol. 18 No. 2 142
Fludarabine Phosphate 25-mg/mL Injection Vol. 18 No. 2 143
Mecasermin 10-mg/mL Injection Vol. 18 No. 2 144
Methylprednisolone 40-mg/mL Injection Vol. 18 No. 2 145
Polymixin B Injection Vol. 18 No. 2 146
Rocuronium Bromide 10-mg/mL Injection Vol. 18 No. 2 147
Secretin 4 mcg/mL Injection Vol. 18 No. 2 148
Selenium 40-mcg/mL Injection Vol. 18 No. 2 149
Sincalide 1-mcg/mL Injection Vol. 18 No. 2 150
Testosterone Enanthate 200-mg/mL Injection Vol. 18 No. 2 151
Chemical and Physical Compatibility of an Intravenous Solution of Epinephrine with Calcium Chloride Vol. 18 No. 2 152
E-Prescription Errors and Their Resolution in a Community Compounding Pharmacy Vol. 18 No. 2 159
The Standardization of Nonsterile Compounding: A Study in Quality Control and Assessment for Hormone Compounding Vol. 18 No. 2 162
Preparation and Stability Evaluation of Extemporaneous Oral Suspension of Valsartan Using Commercially Available Tablets Vol. 18 No. 2 169
Recharting Your Vision While Remaining True to Your Charter Vol. 18 No. 2 175
PreScription: Déjà Vu All Over Again Vol. 18 No. 3 180
A Brief Survey on Prescriber Beliefs Regarding Compounded Topical Pain Medications Vol. 18 No. 3 182
Compounded Drugs of Value in Outpatient Hospice and Palliative Care Practice Vol. 18 No. 3 190
Literature Review: The Dual Role of Domperidone in Gastroparesis and Lactation Vol. 18 No. 3 203
The U.S. Food and Drug Administration Responds to the International Academy of Compounding Pharmacists' Outsourcing Letter Vol. 18 No. 3 208
Marketing: Effective Use of Advertisements on Your Website Vol. 18 No. 3 210
Quality Control Analytical Methods: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 1 Vol. 18 No. 3 213
Quality Control Analytical Methods: Establishing Powder-handling Workflow Practices and Standard Operating Procedures: Compounding Pharmacy and Safety Vol. 18 No. 3 222
Basics of Compounding: Tips and Hints, Part 3: Compounding with Ointments, Creams, Pastes, Gels, and Gel-creams Vol. 18 No. 3 228
Calculations Vol. 18 No. 3 231
Atorvastatin 10-mg or 20-mg Capsules Vol. 18 No. 3 232
Bumetanide 0.5-mg, 1-mg, or 2-mg Capsules Vol. 18 No. 3 233
Bupivacaine Hydrochloride 0.5% Injection Vol. 18 No. 3 234
Butorphanol Tartrate 10-mg/mL Nasal Spray Vol. 18 No. 3 235
Dibucaine 1% Ointment Vol. 18 No. 3 236
Lidocaine Hydrochloride 1% Injection Vol. 18 No. 3 237
Methotrexate 2.5-mg Capsules Vol. 18 No. 3 238
Naproxen 25-mg/mL Oral Suspension Vol. 18 No. 3 239
Tamoxifen 10-mg or 20-mg Capsules Vol. 18 No. 3 240
Thiothixene 1-mg, 2-mg, 5-mg, or 10-mg Capsules Vol. 18 No. 3 241
Examination of the Order of Incubation for the Recovery of Bacteria and Fungi from Pharmaceutical-grade Cleanrooms Vol. 18 No. 3 242
Investigation of Physical and Chemical Stability of an Ointment with Herbals Vol. 18 No. 3 248
Evaluation of the Stability of Fluoxetine in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date Vol. 18 No. 3 253
Preparation and In Vitro Evaluation of a Pluronic Lecithin Organogel Containing Ricinoleic Acid for Transdermal Delivery Vol. 18 No. 3 256
PostScription: The Fourth Annual Student Pharmacist Compounding Competition: Building Future Leaders in the Industry Vol. 18 No. 3 262
PreScription: Challenging Times Vol. 18 No. 4 268
Vial Washers for the Compounding Pharmacy: Ensuring Preparation Safety Vol. 18 No. 4 270
Compounded Pain Formulations: What is the Evidence? Vol. 18 No. 4 278
Oral Mucosal Immunotherapy Using a Toothpaste Delivery System for the Treatment of Allergic Rhinitis Vol. 18 No. 4 287
Color Additives: Legislative Perspective in the United States, Europe, Australia, and India Vol. 18 No. 4 293
400 Attendees Convene in Washington, D.C., for the 20th Annual Compounders on Capitol Hill Vol. 18 No. 4 302
Quality Control: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 2 Vol. 18 No. 4 305
Basics of Compounding Sterile Preparations: Nomenclature and Considerations Vol. 18 No. 4 313
Basics of Compounding: Tips and Hints, Part 4: Lollipops/Lozenges, Gummy Bears, Patches, Flavoring/Coloring, Sweeteners, and Packaging Vol. 18 No. 4 318
Calculations Vol. 18 No. 4 320
Atracurium Besylate 10-mg/mL Injection, Preserved Vol. 18 No. 4 322
Barium Sulfate Suspension Vol. 18 No. 4 323
Calcitriol 1-mcg/mL Injection Vol. 18 No. 4 324
Chloramphenicol 100-mg/mL Injection Vol. 18 No. 4 325
Chlorothiazide 50-mg/mL Oral Suspension Vol. 18 No. 4 326
Choline Magnesium Trisalicylate Liquid Vol. 18 No. 4 327
Denileukin Diftitox 150-mcg/mL Injection Vol. 18 No. 4 328
Indigo Carmine Injection Vol. 18 No. 4 329
Propranolol Hydrochloride 1-mg/mL Injection Vol. 18 No. 4 330
Zinc 1-mg/mL Injection Vol. 18 No. 4 331
Evaluation of Percutaneous Absorption Performance for Human Female Sexual Steroids into Pentravan Cream Vol. 18 No. 4 332
Assessing the Use of Food Coloring as an Appropriate Visual Guide for Homogenously Mixed Capsule Powders in Extemporaneous Compounding Vol. 18 No. 4 341
Evaluation of the Stability of Promethazine Hydrochloride in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date Vol. 18 No. 4 345
Evaluation of the Stability of Ketoprofen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date Vol. 18 No. 4 348
PostScription: Responsibilities of a Compounding Pharmacist Vol. 18 No. 4 351
PreScription: What is a Compounding Pharmacist? Vol. 18 No. 5 356
Roboticized Compounding of Oncology Drugs in a Hospital Pharmacy Vol. 18 No. 5 358
To Compound or Not to Compound: A Veterinary Transdermal Discussion Vol. 18 No. 5 366
Autologous Serum Eye Drops for Severe Dry Eye Syndrome in a Patient with Chronic Graft-vs-Host Disease: A Case Report Vol. 18 No. 5 370
Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A Vol. 18 No. 5 379
Health Care in Belarus in the 19th and 20th Centuries Vol. 18 No. 5 382
Compounding Practices in a Portuguese Community Pharmacy Vol. 18 No. 5 392
Basics of Compounding: Certification of Sterile Equipment and Facilities: What Pharmacists Need to Know Vol. 18 No. 5 397
Basics of Compounding: Tips and Hints, Part 5: Facilities and Equipment Vol. 18 No. 5 401
Marketing: Tips on Dealing With a Healthcare Practititioner's No-Rep Policy Vol. 18 No. 5 406
Calculations Vol. 18 No. 5 407
Azithromycin 100-mg/mL Injection Vol. 18 No. 5 408
Bacitracin Topical Ointment Vol. 18 No. 5 409
Dexpanthenol 250-mg/mL Injection Vol. 18 No. 5 410
Ephedrine Sulfate 50-mg/mL Injection Vol. 18 No. 5 411
Fluorescein 100-mg/mL Injection Vol. 18 No. 5 412
Indocyanine green 2.5-mg/mL Injection Vol. 18 No. 5 413
Phenylephrine Hydrochloride 2.5%-Ophthalmic Solution Vol. 18 No. 5 414
Sulfamethoxazole and Trimethoprim Oral Solution Vol. 18 No. 5 415
Sumatriptan Succinate 12-mg/mL Injection Vol. 18 No. 5 416
Tranexamic Acid 100-mg/mL Injection Vol. 18 No. 5 417
Stability and In Vitro Toxicity of an Infliximab Eye Drop Formulation Vol. 18 No. 5 418
Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition Vol. 18 No. 5 427
Stability of Tranexamic Acid in 0.9% Sodium Chloride, Stored in Type 1 Glass Vials and Ethylene/Propylene Copolymer Plastic Containers Vol. 18 No. 5 432
PostScription: The Future of Veterinary Compounding Vol. 18 No. 5 438
PreScription: "Named Formulas" Database Available Vol. 18 No. 6 444
Depyrogenation Options for the Compounding Cleanroom Vol. 18 No. 6 446
Standards of Practice, Professional Judgment, and Scientific Evidence to Establish and Extend a Beyond-Use Date Vol. 18 No. 6 456
Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Medications in a Rural Setting: A Case Study from the Delmarva Peninsula Vol. 18 No. 6 462
Compounding Legislation: Focus Shifts to States Vol. 18 No. 6 470
Quality Control: Can Compounding Pharmacy Learn from the Automotive Industry? Vol. 18 No. 6 475
Basics of Compounding: Unique and Special Characteristics of Sterile Dosage Forms Vol. 18 No. 6 479
Basics of Compounding: Tips and Hints, Part 6: Prescription Evaluation, Calculations, Ingredients, Quality-Assurance Practices, Patient Counseling, Shipping and Distribution, Miscellaneous Vol. 18 No. 6 486
Marketing: Using Facebook to Market Your Compounding Pharmacy Vol. 18 No. 6 490
Calculations Vol. 18 No. 6 492
Clarithromycin 250-mg or 500-mg Capsules Vol. 18 No. 6 494
Dexmedetomidine 100 mcg/mL Injection Vol. 18 No. 6 495
Dexmethylphenidate Hydrochloride 2.5-mg, 5-mg, or 10-mg Capsules Vol. 18 No. 6 496
Leucovorin 10-mg/mL Injection Vol. 18 No. 6 497
Levocarnitine 200-mg/mL Injection Vol. 18 No. 6 498
Methazolamide 25-mg or 50-mg Capsules Vol. 18 No. 6 499
Methylene Blue 10-mg/mL Injection Vol. 18 No. 6 500
Methylphenidate Hydrochloride 10-mg Capsules Vol. 18 No. 6 501
Oxacillin Sodium 167-mg/mL Injection Vol. 18 No. 6 502
Tamsulosin Hydrochloride 0.2-mg Capsules Vol. 18 No. 6 503
Skin Penetration and Antinociception of Topical Gabapentin Formulations Vol. 18 No. 6 504
In Vitro Skin Penetration and Skin Content of Progesterone from Various Topical Formulations Vol. 18 No. 6 512
Effect of Emulsifier Pairs on Physical Stability of Emulsions Containing Three Different Natural Oils Vol. 18 No. 6 516
High-Performance Liquid Chromatographic Method Optimization for Ondansetron Assay in Extemporaneous Topical Gel and in Marketed Products Vol. 18 No. 6 520
PostScription: Pharmacy Compounding Accreditation Board: Past, Present, and Future Vol. 18 No. 6 526